Biosound Esaote joins Acuson, a Siemens company, Royal Philips Electronics and General Electric as a licensee of the tissue harmonic imaging (THI) technology. Shaun Kirkpatrick, president and CEO
The existing agreement with Janssen Pharmaceutica already covers the EU, Eastern Europe, Russia, the Middle-East and Africa. All the commercial and contractual conditions remain in effect. The product
ENMD-2076 is a novel, dual-acting, kinase inhibitor with potent activity against Aurora A and tyrosine kinases linked to promoting cancer and inflammatory diseases. The company claims that ENMD-2076
Watson’s Clarithromycin extended-release product is the generic equivalent to Abbott’s Biaxin XL, which is indicated to treat or prevent infections that are proven or strongly suspected to be
The Phase II randomized, controlled open-label study enrolled a total of 67 patients with mildly infected diabetic foot ulcers at 15 US sites. Three treatment arms were evaluated:
The company expects to raise an additional $1.8 million in a second tranche, which is scheduled to close on February 29, 2008, resulting in total net proceeds of
XenoPort’s randomized, parallel-group, double-blind, placebo-controlled Phase II clinical trial of XP19986 is designed to evaluate the efficacy, safety and tolerability of a sustained-release formulation of XP19986 (designated as
Under the terms of the agreement, Centocor will have rights to utilize the deltaPhase technology in their research. PhaseBio’s deltaPhase technology is said to offer new solutions for
The Phase III trials will compare apricitabine (ATC) to the current standard of care in HIV–infected patients who are resistant to current drugs. The program is being conducted
James Hutchinson and his team will remain in senior management roles in the combined Sunrise/American Clinical Services (ACS) business. The ACS transaction follows on from the recently completed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.